WEKO3
アイテム
{"_buckets": {"deposit": "dc589ef8-638a-4526-aa3e-0d77816f1b9b"}, "_deposit": {"created_by": 2, "id": "797", "owners": [2], "pid": {"revision_id": 0, "type": "depid", "value": "797"}, "status": "published"}, "_oai": {"id": "oai:nagasaki-u.repo.nii.ac.jp:00000797", "sets": ["26"]}, "author_link": ["3661", "3666", "3653", "3669", "3658", "3667", "3657", "3655", "3654", "3660", "3672", "3662", "3665", "3668", "3671", "3663", "3664", "3656", "3670", "3659"], "item_2_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2020-04-20", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "8", "bibliographicPageEnd": "1086", "bibliographicPageStart": "1081", "bibliographicVolumeNumber": "59", "bibliographic_titles": [{"bibliographic_title": "Internal Medicine"}]}]}, "item_2_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Secondary pulmonary alveolar proteinosis (sPAP) is a complication of myelodysplastic syndrome (MDS). A 60-year-old woman was diagnosed with MDS with excess blasts-1. Fifty-four months after the initial diagnosis, treatment with azacitidine was initiated. Seventy-three months after the diagnosis, a bone marrow examination revealed increased myeloblasts, at which time computed tomography showed diffuse ground-glass opacities and interlobular septal thickening in the bilateral lower lung fields. A lung biopsy revealed the presence of PAP; therefore, the clinical diagnosis of MDS/sPAP was confirmed. Careful attention should be paid to the development of sPAP in MDS patients with pulmonary lesions during azacitidine treatment.", "subitem_description_type": "Abstract"}]}, "item_2_description_63": {"attribute_name": "引用", "attribute_value_mlt": [{"subitem_description": "Internal Medicine, 59(8), pp.1081-1086; 2020", "subitem_description_type": "Other"}]}, "item_2_publisher_33": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "The Japanese Society of Internal Medicine"}]}, "item_2_relation_12": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type": "isIdenticalTo", "subitem_relation_type_id": {"subitem_relation_type_id_text": "10.2169/internalmedicine.3770-19", "subitem_relation_type_select": "DOI"}}]}, "item_2_rights_13": {"attribute_name": "権利", "attribute_value_mlt": [{"subitem_rights": "c 2020 The Japanese Society of Internal Medicine. The Internal Medicine is an Open Access journal distributed under license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/)."}]}, "item_2_source_id_7": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "09182918", "subitem_source_identifier_type": "ISSN"}]}, "item_2_source_id_8": {"attribute_name": "EISSN", "attribute_value_mlt": [{"subitem_source_identifier": "13497235", "subitem_source_identifier_type": "ISSN"}]}, "item_2_text_62": {"attribute_name": "出版者別言語", "attribute_value_mlt": [{"subitem_text_value": "日本内科学会"}]}, "item_2_version_type_16": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Hashimoto, Miki"}], "nameIdentifiers": [{"nameIdentifier": "3653", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Itonaga, Hidehiro"}], "nameIdentifiers": [{"nameIdentifier": "3654", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nannya, Yasuhito"}], "nameIdentifiers": [{"nameIdentifier": "3655", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Taniguchi, Hirokazu"}], "nameIdentifiers": [{"nameIdentifier": "3656", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Fukuda, Yuichi"}], "nameIdentifiers": [{"nameIdentifier": "3657", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Furumoto, Takafumi"}], "nameIdentifiers": [{"nameIdentifier": "3658", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Fujioka, Machiko"}], "nameIdentifiers": [{"nameIdentifier": "3659", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kasai, Sachie"}], "nameIdentifiers": [{"nameIdentifier": "3660", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Taguchi, Masataka"}], "nameIdentifiers": [{"nameIdentifier": "3661", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Taniguchi, Hiroaki"}], "nameIdentifiers": [{"nameIdentifier": "3662", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Sato, Shinya"}], "nameIdentifiers": [{"nameIdentifier": "3663", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Sawayama, Yasushi"}], "nameIdentifiers": [{"nameIdentifier": "3664", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Atogami, Sunao"}], "nameIdentifiers": [{"nameIdentifier": "3665", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Iwasaki, Keisuke"}], "nameIdentifiers": [{"nameIdentifier": "3666", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Hata, Tomoko"}], "nameIdentifiers": [{"nameIdentifier": "3667", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Soda, Hiroshi"}], "nameIdentifiers": [{"nameIdentifier": "3668", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Moriuchi, Yukiyoshi"}], "nameIdentifiers": [{"nameIdentifier": "3669", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nakata, Koh"}], "nameIdentifiers": [{"nameIdentifier": "3670", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ogawa, Seishi"}], "nameIdentifiers": [{"nameIdentifier": "3671", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Miyazaki, Yasushi"}], "nameIdentifiers": [{"nameIdentifier": "3672", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2020-12-18"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "IntMed59_1081.pdf", "filesize": [{"value": "1.9 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 1900000.0, "url": {"label": "IntMed59_1081.pdf", "url": "https://nagasaki-u.repo.nii.ac.jp/record/797/files/IntMed59_1081.pdf"}, "version_id": "b610664e-e26c-428b-940c-f13a33d0520a"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "myelodysplastic syndromes", "subitem_subject_scheme": "Other"}, {"subitem_subject": "secondary pulmonary alveolar proteinosis", "subitem_subject_scheme": "Other"}, {"subitem_subject": "azacitidine", "subitem_subject_scheme": "Other"}, {"subitem_subject": "umbilical cord blood transplantation", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Secondary Pulmonary Alveolar Proteinosis Following Treatment with Azacitidine for Myelodysplastic Syndrome", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Secondary Pulmonary Alveolar Proteinosis Following Treatment with Azacitidine for Myelodysplastic Syndrome"}]}, "item_type_id": "2", "owner": "2", "path": ["26"], "permalink_uri": "http://hdl.handle.net/10069/39981", "pubdate": {"attribute_name": "公開日", "attribute_value": "2020-05-19"}, "publish_date": "2020-05-19", "publish_status": "0", "recid": "797", "relation": {}, "relation_version_is_last": true, "title": ["Secondary Pulmonary Alveolar Proteinosis Following Treatment with Azacitidine for Myelodysplastic Syndrome"], "weko_shared_id": -1}
Secondary Pulmonary Alveolar Proteinosis Following Treatment with Azacitidine for Myelodysplastic Syndrome
http://hdl.handle.net/10069/39981
http://hdl.handle.net/10069/399812b1a8614-9bd2-42d9-802b-20b5061dd4d8
名前 / ファイル | ライセンス | アクション |
---|---|---|
IntMed59_1081.pdf (1.9 MB)
|
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2020-05-19 | |||||
タイトル | ||||||
タイトル | Secondary Pulmonary Alveolar Proteinosis Following Treatment with Azacitidine for Myelodysplastic Syndrome | |||||
言語 | ||||||
言語 | eng | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | myelodysplastic syndromes | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | secondary pulmonary alveolar proteinosis | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | azacitidine | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | umbilical cord blood transplantation | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
著者 |
Hashimoto, Miki
× Hashimoto, Miki× Itonaga, Hidehiro× Nannya, Yasuhito× Taniguchi, Hirokazu× Fukuda, Yuichi× Furumoto, Takafumi× Fujioka, Machiko× Kasai, Sachie× Taguchi, Masataka× Taniguchi, Hiroaki× Sato, Shinya× Sawayama, Yasushi× Atogami, Sunao× Iwasaki, Keisuke× Hata, Tomoko× Soda, Hiroshi× Moriuchi, Yukiyoshi× Nakata, Koh× Ogawa, Seishi× Miyazaki, Yasushi |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Secondary pulmonary alveolar proteinosis (sPAP) is a complication of myelodysplastic syndrome (MDS). A 60-year-old woman was diagnosed with MDS with excess blasts-1. Fifty-four months after the initial diagnosis, treatment with azacitidine was initiated. Seventy-three months after the diagnosis, a bone marrow examination revealed increased myeloblasts, at which time computed tomography showed diffuse ground-glass opacities and interlobular septal thickening in the bilateral lower lung fields. A lung biopsy revealed the presence of PAP; therefore, the clinical diagnosis of MDS/sPAP was confirmed. Careful attention should be paid to the development of sPAP in MDS patients with pulmonary lesions during azacitidine treatment. | |||||
書誌情報 |
Internal Medicine 巻 59, 号 8, p. 1081-1086, 発行日 2020-04-20 |
|||||
出版者 | ||||||
出版者 | The Japanese Society of Internal Medicine | |||||
出版者別言語 | ||||||
日本内科学会 | ||||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 09182918 | |||||
EISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 13497235 | |||||
DOI | ||||||
関連タイプ | isIdenticalTo | |||||
識別子タイプ | DOI | |||||
関連識別子 | 10.2169/internalmedicine.3770-19 | |||||
権利 | ||||||
権利情報 | c 2020 The Japanese Society of Internal Medicine. The Internal Medicine is an Open Access journal distributed under license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/). | |||||
著者版フラグ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
引用 | ||||||
内容記述タイプ | Other | |||||
内容記述 | Internal Medicine, 59(8), pp.1081-1086; 2020 |